Breg-ging rights

Duke University School of Medicine researchers have developed a way to grow large quantities of regulatory B cells.¹ The team used an infusion of B_reg cells to suppress a murine form of multiple sclerosis and now wants to test the immunomodulatory cells in other autoimmune diseases. They are hoping to launch a company based on the technology.

B_reg cells produce the anti-inflammatory cytokine IL-10 and can counteract excessive immune activation in autoimmune and inflammatory diseases.²...